Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Industry Focus Switzerland.
Press releases published on May 19, 2025
CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies
GlobeNewswire
·
May 19, 2025
-Collaboration brings together complementary capabilities to co-develop and co-commercialize SRSD107, a next generation, long-acting Factor XI (FXI) small interfering RNA (siRNA) for the treatment of thromboembolic disorders- -SRSD107 demonstrated peak …
Double Triomphe pour XS.com au Sommet des Traders 2025 : Reconnu pour l'Excellence en Confiance et Retraits
EIN Presswire
·
May 19, 2025
SWITZERLAND, May 19, 2025 /Business News/ -- XS.com, le fournisseur mondial de services FinTech et financiers, s'est distingué au premier plan lors du Forex Traders Summit Dubai 2025 qui s'est tenu les 14 et 15 mai au Festival Arena de Dubaï, en …
STMicroelectronics Announces Status of Common Share Repurchase Program
GlobeNewswire
·
May 19, 2025
STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from May 12, 2025 to May 16, 2025 AMSTERDAM – May 19, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global …
International Petroleum Corporation Announces Results of Normal Course Issuer Bid
GlobeNewswire
·
May 19, 2025
TORONTO , May 19, 2025 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 146,900 IPC common shares (ISIN: CA46016U1084) during the period of …
Molecular Partners to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 19, 2025
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“ …